Direction, evidence grade, and study type are AI-generated labels (gpt-5-mini), not human-verified. Syntheses are LLM-written. "Tensions" are machine-detected candidates, not confirmed contradictions. A research-acceleration tool, not peer review.
How this is built →
1Distinct papers
1Unique collaborators
1/1OpenAlex citation coverage
Publication dates unavailable. Corpus fetch span: 2026.
Identity provenance
Provider IDs
- Openalex:
A5133102675
ORCID evidence
No valid ORCID is stored.
Observed aliases (1)
- Xiaoyu Zhou (openalex, provider refresh)
Topics and outcomes in this view
Assessment themes
- Innovation: 1 paper
- Productivity: 1 paper
Claim outcomes
- Ai Safety And Ethics: 1 paper
- Innovation Output: 1 paper
- Organizational Efficiency: 1 paper
- Other: 1 paper
- Output Quality: 1 paper
- Task Completion Time: 1 paper
Papers in the OpenAlex view
Latest stored OpenAlex author observations only. Citation counts below are from the same provider and are not combined with other services.
Scroll the table horizontally to see every column.
| Paper | Author evidence | Date | Provider citations |
|---|---|---|---|
| Advanced AI molecular representations and generative models promise to speed drug discovery by predicting PD and toxicity earlier and enabling de novo design; but most demonstrated gains are in silico or preclinical and depend critically on data quality, 3D fidelity and still-maturing quantum approaches.semantic_scholar | Xiaoyu Zhou provider id |
Fetched 2026-04-20 | 4 |
Citation observation summary
OpenAlex supplied counts for 1 of 1 papers in this view; 0 are missing. The observed paper counts sum to 4 cumulative citations. This is a coverage summary, not an author score or h-index.